Data as of:
brimindinvest.com / compare / dov-vs-emrLIVE
DOV
Dover Corporation · Industrials
$188.97
-8.74% this month
VERSUS
COMPARE
EMR
Emerson Electric Co. · Industrials
$147.00
-9.91% this month
Comparison scoreboard
DOV LEADS 4/5
AI Scorei
DOV 52.9
EMR 52.3
1Y Returni
DOV +9.90%
EMR +8.36%
Fwd P/Ei
DOV 17.06
EMR 21.42
Target Up.i
DOV +24.26%
EMR +10.72%
Op. Margini
DOV 18.69%
EMR 26.92%
Metrics last refreshed: 9/16/2026
Quick take

DOV vs EMR Stock Comparison: AI Score, Valuation, Performance and Upside

ShareXLinkedInRedditFacebookWhatsApp

Dover and Emerson Electric are both diversified industrial conglomerates that have actively reshaped their portfolios, but Dover maintains a broader multi-segment industrial manufacturing structure while Emerson has increasingly concentrated around automation software and solutions.

Dover offers diversified industrial exposure with a long dividend growth track record, while Emerson offers a more concentrated bet on the automation software transition. Consider whether you prefer Dover's diversified stability or Emerson's automation-focused growth positioning.

Live analysis · updated 9/16/2026

DOV holds the edge across 4 of 5 key metrics in this comparison. DOV leads on both 1-year return (+9.90%) and forward P/E quality (17.06x vs 21.42x for EMR), a relatively favorable combination of momentum and valuation. EMR leads on both revenue growth (7.00%) and operating margin (26.92%), suggesting a stronger fundamental setup on both dimensions. Analyst consensus implies meaningfully more upside for DOV (+24.26%) than for EMR (+10.72%).

Normalized 1Y performance
DOV
EMR
Recent returns
DOV
EMR
Analyst price targets & sentiment

Human Wall Street analysts' price targets, typically implying a ~12-month view — a separate signal from this site's own AI Prediction Signal further down the page, which is a 5-/30-day machine-learning forecast based on price history alone.

DOV
Price target range
analyst mean$246.89
current price$188.97
+24.3% upside to analyst mean
EMR
Price target range
analyst mean$171.81
current price$147.00
+10.7% upside to analyst mean
Who should consider this stock?
DOV may suit investors who:
  • Want diversified exposure across multiple industrial manufacturing segments and end markets
  • Value a long track record of consistent dividend growth and disciplined capital allocation
  • Believe active portfolio reshaping through acquisitions and divestitures will continue sharpening margins
  • Prefer a broad industrial conglomerate over a more narrowly focused automation pure-play
EMR may suit investors who:
  • Believe the shift toward automation software and solutions will drive higher-margin, recurring revenue growth
  • Value Emerson's global installed base supporting durable services and upgrade revenue
  • Are comfortable with ongoing integration risk as the portfolio concentrates around core automation competencies
  • Want exposure to the broader industrial automation and digitalization theme
Performance & AI score
Performance & AI score
MetricDOVEMR
AI scorei52.952.3
AI ranki#371#401
Latest closei$188.97$147.00
1M returni-8.74%-9.91%
6M returni-11.62%+10.95%
1Y returni+9.90%+8.36%
$10,000 invested — hypothetical growth (dividends reinvested)

How much would $10,000 be worth today if invested at the start of each period, with all dividends reinvested?

$10,000 invested — hypothetical growth (dividends reinvested)
PeriodDOVEMR
1Y ago$10.95K (+9.5%)
started 2025-09-16
$11.39K (+13.9%)
started 2025-09-16
5Y ago$12.74K (+27.4%)
started 2021-09-17
$17.92K (+79.2%)
started 2021-09-17
10Y ago$45.83K (+358.3%)
started 2016-09-19
$46.18K (+361.8%)
started 2016-09-19

Hypothetical — past performance does not guarantee future results.

Valuation & upside potential
Valuation & upside potential
MetricDOVEMR
Market capi$26.76B$86.56B
Trailing P/Ei24.0234.03
Forward P/Ei17.0621.42
Price/SalesiN/AN/A
EV/Revenuei3.365.27
Analyst targeti$246.89$171.81
Target upsidei+24.26%+10.72%
Growth, profitability & risk
Growth, profitability & risk
MetricDOVEMR
Revenue growthi6.90%7.00%
Earnings growthi14.10%23.00%
EPS growthi+14.10%+23.00%
FCF margini+10.76%+19.89%
Operating margini18.69%26.92%
Profit margini13.48%13.83%
ROIC proxyi14.91%12.80%
Return on equityi14.91%12.80%
Dividend yieldi1.06%1.43%
Payout ratioi25.15%47.98%
Dividend growth streakiNo increase yetNo increase yet
Betai1.161.24
Debt/equityi42.3267.68
Current ratioi1.980.90
Quick ratioi1.310.62
Correlation

Over the past year, DOV and EMR have moved moderately in the same direction (correlation of 0.56), based on daily returns.

1Y
0.56
-1.0+1.0
5Y
0.67
-1.0+1.0
10Y
0.72
-1.0+1.0
Drawdown & downside risk

Lower drawdown and smaller single-period drops generally indicate a smoother ride, though they do not guarantee lower future risk.

1Y risk snapshot
DOV max drawdowni19.69%
EMR max drawdowni23.74%
DOV max wkly dropi9.06%
EMR max wkly dropi8.22%
5Y risk snapshot
DOV max drawdowni35.56%
EMR max drawdowni29.61%
DOV max wkly dropi14.35%
EMR max wkly dropi15.00%
10Y risk snapshot
DOV max drawdowni45.24%
EMR max drawdowni50.77%
DOV max wkly dropi27.13%
EMR max wkly dropi28.66%
Performance metrics by period
Performance metrics by period
PeriodMetricDOVEMR
1YGrowthi+9.50%+13.93%
CAGRi+9.52%+13.96%
Volatilityi26.06%31.83%
Sharpe ratioi0.310.43
Sortino ratioi0.460.61
Max drawdowni19.69%23.74%
Current drawdowni19.00%10.57%
Avg drawdowni5.81%7.91%
Ulcer Indexi7.71%9.91%
Max daily dropi7.80%6.26%
Max wkly dropi9.06%8.22%
5YGrowthi+21.61%+64.99%
CAGRi+3.99%+10.54%
Volatilityi25.21%27.77%
Sharpe ratioi0.100.34
Sortino ratioi0.150.49
Max drawdowni35.56%29.61%
Current drawdowni19.00%10.57%
Avg drawdowni13.00%8.46%
Ulcer Indexi16.04%10.39%
Max daily dropi9.10%8.65%
Max wkly dropi14.35%15.00%
10YGrowthi+293.16%+259.54%
CAGRi+14.69%+13.66%
Volatilityi26.82%29.28%
Sharpe ratioi0.480.43
Sortino ratioi0.690.61
Max drawdowni45.24%50.77%
Current drawdowni19.00%10.57%
Avg drawdowni9.26%9.22%
Ulcer Indexi12.93%11.97%
Max daily dropi16.31%18.96%
Max wkly dropi27.13%28.66%
AI Prediction Signali
Members only
Next 5 trading days
DOV
+2.8%BUY
EMR
+1.1%HOLD
Next 30 trading days
DOV
+6.4%BUY
EMR
+3.2%HOLD

Sign up to unlock AI price predictions

ML model trained on historical prices · 14-day free trial · No credit card required
Business comparison
Business comparison
CategoryDOVEMR
CompanyDover CorporationEmerson Electric Co.
SectorIndustrialsIndustrials
IndustrySpecialty Industrial MachinerySpecialty Industrial Machinery
Core businessA diversified global manufacturer producing equipment and components across segments including engineered products, clean energy and fueling, imaging and identification, and pumps and process solutions.A global technology and software company providing automation solutions and industrial software for process, hybrid, and discrete manufacturing customers across a range of end markets.
Investor focusOrganic revenue growth across diversified segments, portfolio reshaping through acquisitions and divestitures, and margin expansion progress.Automation software and solutions revenue growth, margin expansion following portfolio simplification, and integration progress from recent acquisitions.
DOV strengths
  • Diversified segment structure spreads exposure across multiple industrial end markets, reducing single-cycle dependency
  • Active portfolio management through targeted acquisitions and divestitures has sharpened focus on higher-margin niches
  • Long track record of consistent dividend growth reflects disciplined capital allocation
EMR strengths
  • Increasing focus on automation software and solutions positions the company toward higher-margin, recurring revenue streams
  • Portfolio simplification efforts have concentrated the business around core automation competencies
  • Global installed base across process and discrete manufacturing provides a durable services and upgrade revenue stream
Risks to watch — DOV
  • Diversified conglomerate structure can make it harder for investors to cleanly value individual segment growth drivers
  • Some segments remain exposed to cyclical industrial capital spending and end-market demand fluctuations
  • Portfolio reshaping activity introduces integration and divestiture execution risk
Risks to watch — EMR
  • Transition toward a more automation-software-centric portfolio still carries execution and integration risk
  • Underlying end markets remain tied to capital spending cycles in energy, chemicals, and manufacturing
  • Competitive automation and industrial software landscape includes both established players and newer entrants
Frequently asked questions
DOV offers diversified industrial exposure across multiple manufacturing segments with a long dividend growth track record. EMR offers a more concentrated bet on the automation software and solutions transition. The better choice depends on whether you prefer diversified industrial stability or automation-focused growth.
Free public comparison

Want deeper AI forecasts?

This comparison page is public and free forever. Subscribers can unlock saved watchlists, full AI rankings, detailed forecasts, and interactive analysis tools.

Related comparisons
More comparisons
Browse all 1,000 comparisons
ShareXLinkedInRedditFacebookWhatsApp